Regenxbio Inc banner

Company Overview

Business Description

Sector
Health Care
Industry
Biotechnology
Headquarters
United States of America US
Employees
371
IPO date
Sep 17, 2015

Regenxbio is a biotechnology company that develops gene therapy medicines. It works by designing viral vectors that can deliver working genes into a patient’s cells, mainly for rare and serious diseases. The company’s business is built around research, clinical development, and licensing its gene therapy technology to drug makers that want to use it in their own programs.

The company does not sell consumer products. Its main customers are pharmaceutical and biotech partners, as well as the healthcare system that ultimately uses the medicines it helps create. Regenxbio makes money through collaboration payments, licensing fees, milestone payments, and royalties tied to partnered products, along with potential sales revenue if any of its own therapies reach the market.

What makes Regenxbio different is its role as both a drug developer and a technology supplier. Instead of only betting on one medicine, it also earns from a platform that can be used across many gene therapy programs. That gives it exposure to the broader gene therapy market while keeping its focus on diseases where a one-time genetic treatment could be a better fit than long-term drug use.

Regenxbio Inc Investor Relations

Address
9804 Medical Center Drive
Rockville, Maryland
United States of America

Business Segments

Gene therapy programs

Regenxbio develops gene medicines that are meant to give patients a working copy of a gene or help the body make a needed protein. The company focuses on therapies for rare and serious diseases and runs the research, tes...

Customers and revenue model

Technology licensing

Regenxbio also licenses its gene delivery technology to other drugmakers that want to use it in their own gene therapy programs. These partners use the company’s platform to build and test their own treatments.

Customers and revenue model

Management

Mr. Curran M. Simpson M.S.

President, CEO & Director

Biography unavailable

Dr. Olivier Danos Ph.D.

Executive VP & Chief Scientific Officer

Biography unavailable

Mr. Vittal K. Vasista

Advisor

Biography unavailable

Dr. Stephen Pakola M.D.

Executive VP & Chief Medical Officer

Biography unavailable

Mr. Mitchell Chan M.B.A.

Executive VP & CFO

Biography unavailable

Mr. Patrick J. Christmas II, J.D.

Executive VP & Chief Legal Officer

Biography unavailable

Ms. Shiva G. Fritsch

Chief Communications & People Officer

Biography unavailable

Dr. Ram Palanki Pharm.D.

Executive VP of Commercial Strategy & Operations

Biography unavailable

1 / 8